CA2288027A1 - Bradykinin analogs as selective inhibitors of cell activation - Google Patents

Bradykinin analogs as selective inhibitors of cell activation Download PDF

Info

Publication number
CA2288027A1
CA2288027A1 CA002288027A CA2288027A CA2288027A1 CA 2288027 A1 CA2288027 A1 CA 2288027A1 CA 002288027 A CA002288027 A CA 002288027A CA 2288027 A CA2288027 A CA 2288027A CA 2288027 A1 CA2288027 A1 CA 2288027A1
Authority
CA
Canada
Prior art keywords
pro
arg
amino acids
thrombin
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002288027A
Other languages
English (en)
French (fr)
Inventor
Alvin H. Schmaier
Ahmed A.K. Hasan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2288027A1 publication Critical patent/CA2288027A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • C07K5/0817Tripeptides with the first amino acid being basic the first amino acid being Arg
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043Kallidins; Bradykinins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/18Kallidins; Bradykinins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002288027A 1997-04-23 1998-04-21 Bradykinin analogs as selective inhibitors of cell activation Abandoned CA2288027A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4608597P 1997-04-23 1997-04-23
US60/046,085 1997-04-23
PCT/US1998/008015 WO1998047522A1 (en) 1997-04-23 1998-04-21 Bradykinin analogs as selective inhibitors of cell activation

Publications (1)

Publication Number Publication Date
CA2288027A1 true CA2288027A1 (en) 1998-10-29

Family

ID=21941533

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002288027A Abandoned CA2288027A1 (en) 1997-04-23 1998-04-21 Bradykinin analogs as selective inhibitors of cell activation

Country Status (5)

Country Link
EP (1) EP1019070A4 (ja)
JP (1) JP2001518119A (ja)
CA (1) CA2288027A1 (ja)
IL (1) IL132546A0 (ja)
WO (1) WO1998047522A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544750B1 (en) * 1999-08-17 2003-04-08 Thromgen, Inc. Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
US7879792B2 (en) * 2005-06-02 2011-02-01 The Regents Of The University Of Michigan Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
AU2011336345B2 (en) 2010-12-02 2016-07-07 Becton, Dickinson And Company Blood collection devices containing blood stabilization agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585757A (en) * 1984-07-27 1986-04-29 Texas Tech University Health Sciences Center Hypotensive active peptides
ES2063912T3 (es) * 1989-01-24 1995-01-16 Aphton Corp Composiciones inmunogenicas frente a peptidos de gastrina.
SE468516B (sv) * 1991-06-14 1993-02-01 Kabigen Ab Nya polypeptider vilka kan utvinnas fraan tunntarmen och deras anvaendning
AU2548992A (en) * 1991-08-13 1993-03-16 Temple University - Of The Commonwealth System Of Higher Education Modulation of blood pressure and inhibition of platelet activation with kininogen fragment
AU703256B2 (en) * 1995-06-09 1999-03-25 Regents Of The University Of Michigan, The Bradykinin analogs as selective thrombin inhibitors

Also Published As

Publication number Publication date
JP2001518119A (ja) 2001-10-09
WO1998047522A1 (en) 1998-10-29
EP1019070A1 (en) 2000-07-19
AU7252898A (en) 1998-11-13
AU734935B2 (en) 2001-06-28
EP1019070A4 (en) 2001-05-16
IL132546A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
EP0578728B1 (en) PLATELET AGGREGATION INHIBITORS HAVING HIGH SPECIFICITY FOR GP IIbIIIa
US6982249B1 (en) Bradykinin analogs as selective inhibitors of cell activation
EP0871464B1 (en) Bradykinin analogs as selective thrombin inhibitors
Stewart Bradykinin antagonists: discovery and development
Krstenansky et al. Development of MDL 28,050, a small stable antithrombin agent based on a functional domain of the leech protein, hirudin
US5498601A (en) Platelet aggregation-inhibiting peptides
CA2045692A1 (en) Processes for producing polypeptide inhibitors of platelet activation and methods, combinations and compositions using them
US7879792B2 (en) Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
WO1993003748A1 (en) Modulation of blood pressure and inhibition of platelet activation with kininogen fragment
AU764707B2 (en) Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
CA2288027A1 (en) Bradykinin analogs as selective inhibitors of cell activation
AU734935C (en) Bradykinin analogs as selective inhibitors of cell activation
Stewart et al. Metabolism-resistant bradykinin antagonists: development and applications
AU761624B2 (en) Bradykinin analogs as selective inhibitors of cell activation
US20040220110A1 (en) Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
EP0702696B1 (en) Trifunctional antithrombin and antiplatelet peptides
CA1180006A (en) Therapeutically useful pseudopeptides, compositions containing the same and methods of preparation and use

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20110421